These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33910302)

  • 1. [Consensus of Chinese experts on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2021)].
    ; ; ;
    Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):185-192. PubMed ID: 33910302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2016)].
    ; ;
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):441-52. PubMed ID: 27431065
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases].
    Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):252-6. PubMed ID: 22781625
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chinese expert consensus on diagnosis and treatment of antirheumatic drug-induced liver injury(2024)].
    ; ; ; ; ; ; ;
    Zhonghua Nei Ke Za Zhi; 2024 Aug; 63(8):743-761. PubMed ID: 39069863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interpretation on Consensus on drug-induced liver injury by CIOMS Working Group:liver injury attributed to herbal and dietary supplements].
    Jing J; Wang RL; Bai ZF; Guo YM; He TT; Wang JB; Song HB; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2552-2556. PubMed ID: 37282884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Jian'ganle () versus Hugan Pian (), glucuronolactone and reduced glutathione in prevention of antituberculosis drug-induced liver injury.
    Zhang Q; Zhong FY; Wu M; Zhang XP
    J Huazhong Univ Sci Technolog Med Sci; 2014 Jun; 34(3):450-455. PubMed ID: 24939315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ticlopidine: blood and liver involvement?].
    Biour M; Toussaint P; Duhamel G; Canuel C; Krulick M; Calmus Y
    Therapie; 1982; 37(2):222-4. PubMed ID: 7112492
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of etretinate on blood and liver in rats.
    Sakamoto K; Kasahara T; Nakayama S; Nakai Y; Kudo J
    Jpn J Pharmacol; 1982 Dec; 32(6):1175-8. PubMed ID: 7161968
    [No Abstract]   [Full Text] [Related]  

  • 9. The reply.
    D'Andrea MA; Reddy GK
    Am J Med; 2014 Sep; 127(9):e27. PubMed ID: 25205270
    [No Abstract]   [Full Text] [Related]  

  • 10. The reply.
    D'Andrea MA; Reddy GK
    Am J Med; 2014 Sep; 127(9):e23-4. PubMed ID: 25205268
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China.
    Li X; Wang L; Li D; Niu J; Gao P
    Med Sci Monit; 2019 May; 25():3344-3353. PubMed ID: 31059494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic hepatitis and hematologic disorder in a work environment: A case report.
    Debbabi H; Kchir H; Benzarti A; Majda E; Chaabouni H; Ben Mamai N; Ben Jemaa A
    Tunis Med; 2016 Nov; 94(11):701. PubMed ID: 28994878
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
    McMorran M; Vu D
    CMAJ; 2001 Jul; 165(1):82-3, 86-7. PubMed ID: 11468963
    [No Abstract]   [Full Text] [Related]  

  • 14. Major concerns about study design and clinical biomarker interpretation.
    Wickliffe JK; Wilson MJ; Lichtveld MY
    Am J Med; 2014 Sep; 127(9):e21-2. PubMed ID: 24269658
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients.
    Xin HW; Liu HM; Li YQ; Huang H; Zhang L; Yu AR; Wu XC
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):497-503. PubMed ID: 24691060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse effects of conventional DMARDs and biologic DMARDs].
    Suzuki Y; Saito E; Wakabayashi T; Suwa A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():209-17. PubMed ID: 18074541
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patients.
    Cao YL; Tian ZG; Wang F; Li WG; Cheng DY; Yang YF; Gao HM
    World J Gastroenterol; 2014 Oct; 20(38):13956-65. PubMed ID: 25320533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study methodology prevents interpretation of findings in workers involved in Gulf oil spill cleanup activities.
    Piacentino J; Silver S; Bernard B; DeBord DG; Funk R; Decker J
    Am J Med; 2014 Sep; 127(9):e25-6. PubMed ID: 25205269
    [No Abstract]   [Full Text] [Related]  

  • 19. Risks of isoniazid therapy.
    Brown A
    Ann Intern Med; 1976 Dec; 85(6):828-9. PubMed ID: 999121
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinogenic, hematotoxic and hepatotoxic effects of organic phosphate pesticides.
    Gibel W; Lohs K
    Environ Qual Saf; 1975; 4():232-4. PubMed ID: 1193058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.